Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Ting Liu

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 12, 2019
Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinomaXiao-Yun Li, Qiu-Yan Chen, Xue-Song Sun, et al.
BMC Cancer|February 5, 2020
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA levelSai-Lan Liu, Xue-Song Sun, Hao-Jun Xie, et al.
Cancer Research and Treatment|April 11, 2017
The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma PatientsLi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
JAMA Network Open|December 20, 2021
Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical TrialQing-Nan Tang, Li-Ting Liu, Bin Qi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 11, 2021
Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatmentZi-Jian Lu, Li-Ting Liu, Xue-Song Sun, et al.
BMC Cancer|August 25, 2017
Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control studyYang Li, Qiu-Yan Chen, Lin-Quan Tang, et al.
Med (New York, N.Y.)|March 31, 2026
Efficacy of immunotherapy rechallenge in locoregionally advanced nasopharyngeal carcinoma after progression: A real-world analysisJia-Rui He, Yu-Xin Li, Bao-Cong Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 11, 2021
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinomaJin-Jie Yan, Shan-Shan Guo, Da-Feng Lin, et al.
Annals of Translational Medicine|May 14, 2021
Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort studyQing-Nan Tang, Hui-Zhi Qiu, Xiao-Qing Sun, et al.
Journal of Cancer|May 29, 2018
The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: results from a case-cohort studySai-Lan Liu, Lin-Quan Tang, Qiu-Yan Chen, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|February 12, 2019
Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinomaXiao-Yun Li, Qiu-Yan Chen, Xue-Song Sun, et al.
BMC Cancer|February 5, 2020
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA levelSai-Lan Liu, Xue-Song Sun, Hao-Jun Xie, et al.
Cancer Research and Treatment|April 11, 2017
The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma PatientsLi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
JAMA Network Open|December 20, 2021
Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical TrialQing-Nan Tang, Li-Ting Liu, Bin Qi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 11, 2021
Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatmentZi-Jian Lu, Li-Ting Liu, Xue-Song Sun, et al.
BMC Cancer|August 25, 2017
Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control studyYang Li, Qiu-Yan Chen, Lin-Quan Tang, et al.
Med (New York, N.Y.)|March 31, 2026
Efficacy of immunotherapy rechallenge in locoregionally advanced nasopharyngeal carcinoma after progression: A real-world analysisJia-Rui He, Yu-Xin Li, Bao-Cong Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 11, 2021
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinomaJin-Jie Yan, Shan-Shan Guo, Da-Feng Lin, et al.
Annals of Translational Medicine|May 14, 2021
Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort studyQing-Nan Tang, Hui-Zhi Qiu, Xiao-Qing Sun, et al.
Journal of Cancer|May 29, 2018
The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: results from a case-cohort studySai-Lan Liu, Lin-Quan Tang, Qiu-Yan Chen, et al.
Pageof 13